About the Authors
- Bin Li
-
Contributed equally to this work with: Bin Li, Colin A. Flaveny
Affiliation Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America
- Colin A. Flaveny
-
Contributed equally to this work with: Bin Li, Colin A. Flaveny
Affiliation Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America
- Camilla Giambelli
-
Affiliation Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America
- Dennis Liang Fei
-
Affiliation Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America
- Lu Han
-
Affiliation Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America
- Brian I. Hang
-
Affiliation Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
- Feng Bai
-
Affiliation Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America
- Xin-Hai Pei
-
Affiliations Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America
- Vania Nose
-
Affiliation Department of Pathology, Miller School of Medicine, University of Miami, Miami, Florida, United States of America
- Oname Burlingame
-
Affiliation Department of Pathology, Jackson Health System, University of Miami, Miami, Florida, United States of America
- Anthony J. Capobianco
-
Affiliations Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America
- Darren Orton
-
Affiliation Stemsynergy Therapeutics Inc., Miami, Florida, United States of America
- Ethan Lee
-
Affiliation Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
- David J. Robbins
-
* E-mail: drobbins@med.miami.edu
Affiliations Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America, Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida, United States of America
Competing Interests
DJR, AJC and EL are founders of StemSynergy Therapeutics Inc. a company commercializing WNT inhibitors, including CK1α agonists. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: BL CAF DJR. Performed the experiments: BL CAF CG LH BIH. Analyzed the data: BL CAF EL DO DLF FB XHP OB VN AJC. Contributed reagents/materials/analysis tools: EL. Wrote the paper: BL CAF DJR.